ReleaseWire Connect

New report on Therapeutic Vaccines are provided to the body during treatment of specific diseases. This vaccine triggers and strengthens the immune response of the body to act against a disease. In 2011, the global therapeutic vaccines market was valued at $294 million. This vaccine has expanded the horizon of chronic disease treatment. However, there is a need to get a vaccine for specific disease to be approved by the FDA. Increasing cases of chronic diseases and need for effective treatment is acting as key driver for this market. Various pharmaceutical companies are working to develop novel vaccines for diseases such as lung cancer, breast cancer, Alzheimer, etc. However, these vaccine developments are in pipeline and yet to be commercialized. Inefficient Research & development and reimbursement policies are primary factors restraining the market. Furthermore, as the market is in nascent stage, strict regulatory implications are also expected to deter growth. However, as the vaccine carries potential to treat many chronic diseases, these restraints would get weaker with time. This report delivers micro level analysis of the therapeutic vaccine market and its opportunities in various disease treatments.

The Thin Film & Printed Battery market provides nano-sized batteries which can be used in various products such as mobile phones, tablets, laptops etc. The global semiconductors market revenue stood at $292 billion in 2012. Thin films & printed batteries are expected to be a significant constituent of the market, as more emphasis is given to nano technologies. One of the key drivers for the growth of the market is that these batteries are environmentally friendly, as the batteries are 40% energy efficient as compared to other batteries. The importance of green technologies is evident as the impact on environment is an essential factor for the development of any new technology. However, the manufacturing process of these batteries is time consuming and prone to defects. This is a key restraint for the market growth, as developers of the technology have to make high investments in research and development to get rid of the defects. Another challenge for the market growth is the requirement of heavy investment in the technology. To overcome this challenge manufacturers have to find out new and cost-effective methods to reduce the investment.

New report on Plastic Healthcare Packaging is a practice of securely packaging of devices, tools, drugs and other healthcare products. The global market for plastic healthcare packaging is expected to reach $87.3 billion in 2011. Increase in demand for healthcare practices promotes the growth for healthcare packaging market. Developed countries are engaged in development of healthcare services that increase the investment on healthcare packaging. Increase in counterfeiting practice in pharmaceutical industries is affecting the growth of plastic healthcare packaging market. However, Asian countries are highly affected by counterfeiting of pharmaceutical products, especially in non-prescribed drugs. The healthcare packaging market is constantly challenged by shifting trends such as the increased use of disposable medical products, an ageing population, outsourcing packaging, child-resistant and tamper-evident packaging. In order to overcome on the challenges of counterfeiting U.S. government passed the Track and Trace Bill under which Drug Quality and Security Act (DQSA) has been issued. DQSA act implemented electronic tracking for food and pharmaceutical packaging. This report provides intelligence about key legislation and regulation according to geographies. Key market trends available for plastic healthcare packaging.

New report on Bio-Renewable Chemical application market analysis: Global bio-renewable chemical application market is segmented into bio-plastic, bio-solvents, bio-cleaners & detergents and other applications. Bio-plastic is normally used as packaging material and it emits very less green house gasses; hence, it has a great demand globally, especially in USA and Europe. In addition, bio-solvent has the maximum demand due to its wide application in industries such as industrial and domestic cleaners, paints & coatings, printing inks, pharmaceutical and personal care products. However, bio-cleaners and detergents are utilized only in detergent industry. Bio-renewable chemical product (platform chemicals) market analysis: Global bio-renewable chemical product market is segmented into Glycerin, Lactic Acid, Succinic Acid and other chemical products. Bio-renewable Glycerin has the largest market size due to its volume-based requirements followed by Lactic acid. Bio-renewable succinic acid's demand increases, as it is used as the main ingredient for pigment and coating in planting and pharmaceutical industry. Bio-renewable chemical competitive market analysis:The key players of global bio-renewable chemical market are BASF, Solazyme, Myriant, Elevance Renewable Sciences, BioAmber, DuPont Industrial Biosciences (Genencor), Lanza Tech, Amyris, ZeaChem and Gevo. In Germany, Evonik Indystries and Lanzatech have signed a three-year research corporate agreement, which would make value addition to its synthetic gas and polymer market.

New report on Photovoltaic is method of generating electricity from solar energy using semiconductors that produce photovoltaic effect. Photovoltaic market has showed leading growth in European countries. Around 74% of world's new PV installation was done in Europe in 2011 PV market covers approximately 2.4% of electricity demand and approximately 5.1% of electricity demand in Europe. Photovoltaic market is strongly driven by decrease in PV technology cost and increase in electricity price. This driving force provides benefits to developing countries such as India, China, and Japan. Change in climatic factors influence the growth of PV market. PV installation rate in Europe is decreased to 55% in 2012 from 74% in 2011. The global PV market is becoming more diversified. Chi na, America, Japan are emerging markets and continue to grow in future. The major market share for photovoltaic comes from utility sector. Mergers & acquisitions and expansion into new and emerging markets will bring success for the photovoltaic markets to increase sales.

New report on Biopharmaceuticals are drugs produced from genetically modified source, which are mainly proteins and nucleic acids. According to IMS Health Market Prognosis, the total market size of pharmaceutical industry was approximately $962.1 billion in 2012. The market for the biopharmaceuticals drug was $149 billion in 2010. The factors driving the market are, increase in regulatory approvals for biotechnology products. One such product is the recombinant DNA-based products, which has high rates of approval from regulatory authorities. The opportunities of this market are the ageing population and increase in the number of diseases. The challenges of this market are the reimbursement and pricing policy that are the limiting factors in the launch of high priced drugs. Key player profiled in the report are Pfizer, Inc., Ranbaxy Laboratories Ltd., Roche Holding AG, Abbott Laboratories, Inc., Bayer AG, Biocon Ltd, Eli Lilly and Company, Genentech, Inc., GlaxoSmithKline, PLC. Johnson & Johnson, Inc., LG Life Sciences and Novartis AG

New report on Encapsulation Food is the process of incorporating food ingredients, enzymes and other materials into capsules. The parent market for the encapsulated food is the global food market, which was $4200 billion in 2012. The awareness of health, demand for convenience food and busy schedules are the major driving factors of the encapsulated food market. The limiting factors of this market are the maintenance of stability of the food during the processing and packaging. The other limiting factor is the size of the capsule. The opportunities of this market are the ongoing high investments due to demand for food that helps in preventing health problems and aging population.

New report on DNA Sequencing is the process of arranging nucleotide molecule of DNA. DNA sequencing market is a segment of life science tools market, which was valued more than $40 billion in 2011. The global market for DNA sequencing is driven by emergence of Human Genome Project that provides cost effective and improved DNA sequencing. For Example, there were more than $ 1 million required to store human genome information in 2007. DNA sequencing is competing with conventional genetic analysis tools. New technologies in conventional genetic analysis compete with DNA sequencing by providing cost effective genetic analysis solutions. The global DNA sequencing market is facing challenges in commercialization of sequencing tools; however, government and research facilities are funding the sequencing technologies so that companies can get opportunities for expanding their businesses in microarray and in vitro diagnostics. This report provides intelligence about current market trends available in DNA sequencing market. The report provides an in depth analysis of key regulations and reimbursement policies for conducting DNA sequencing.

New report on Point Of Care Diagnosis is a process of diagnosing the abnormal condition of the body at the point of care facility (Hospital, Physicians office laboratories, Primary clinics) that gives immediate results. Point of care diagnostic has covered blood glucose testing, drug abuse screening, blood gas and electrolytes analysis, etc. The global market for point of care testing accounted to approximately $5.3 billion which is expected to grow at 7.7%. Increase in patient traffic at diagnostic center, and cost of diagnosis drives the market for POC diagnosis. CTK Biotech Inc., Diagnostics for All (DFA), BioVei Incorporated, DNA Medicine Institute (DMI) are a few companies engaged in medical device manufacturing, with investments in smart, handheld diagnostic devices. Demand for chronic disease diagnosis through smart diagnostic devices challenge POC diagnostic markets. However, increase in investment for development of novel diagnostic devices should resolve this problem. This report provides intelligence about current market trends available in POC diagnosis tool. Report also provides market intelligence with strategies adopted by key market players.

The global Battery Technology market includes primary batteries used in electronic keys, watches, remote controls, toys etc. and secondary batteries used in automotives & aviation and portable & stationery batteries. The global advanced energy storage system market is expected to attain market revenue of $10.8 billion by 2018 at a CAGR of 10% between 2013 and 2018. The battery technology market is a key constituent of the advanced energy storage system market; therefore, the market is expected to have a sustainable growth rate. It is estimated that there would be 40% increase in demand for electricity between 2010 and 2040. The ever increasing demand for electricity is one of the prime drivers for the market as power can be efficiently stored in the batteries. However, some legislation such as the EU Batteries Directive limits the use of some substances such as mercury, lead and cadmium as these substances are not environmentally friendly. This is a major restraint for the market growth as manufacturers have limited resources to explore and produce new and better batteries. Manufacturers are trying to overcome this challenge by engaging in research and development to use other substances for batteries.